SBC Medical Group (NASDAQ:SBC - Get Free Report) is expected to announce its Q4 2024 earnings results before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $56.34 million for the quarter.
SBC Medical Group Stock Performance
NASDAQ:SBC traded down $0.47 during mid-day trading on Friday, reaching $3.28. The stock had a trading volume of 40,686 shares, compared to its average volume of 59,722. The business has a 50-day simple moving average of $4.41. The company has a debt-to-equity ratio of 0.06, a current ratio of 2.79 and a quick ratio of 2.76. SBC Medical Group has a 12 month low of $2.62 and a 12 month high of $12.50.
SBC Medical Group Company Profile
(
Get Free Report)
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
See Also
Before you consider SBC Medical Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SBC Medical Group wasn't on the list.
While SBC Medical Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
